{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/69bc3c857878605e113221f3/6aa56268ff74edfd00b69cc2?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Changing the Future of Pediatric MASLD","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/69bc3c857878605e113221f3/1789223492534-e9078104-1894-4929-b8c1-de8d96b4afb2.jpeg?height=200","description":"<p>Join us for Episode 9 of FISPGHAN Expert Insights, featuring Dr. Tania Mitsinikos from Children’s Hospital Los Angeles and the Keck School of Medicine of USC.</p><p>This episode explores metabolic dysfunction-associated steatotic liver disease (MASLD) as a growing pediatric public health challenge. Dr. Mitsinikos discusses barriers to screening and early detection, practical strategies for sustainable lifestyle change, family-centered care, health inequities, and the policies needed to improve long-term outcomes for children worldwide.</p><p><br></p><p>Hosted by Dr. Natascha Sandy. </p><p>Produced by Dr. Carlos Timossi.</p>","author_name":"FISPGHAN"}